Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Accord Healthcare
Accord Healthcare
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Research & Development
Carthera signs strategic collaboration with Accord Healthcare
Partnership will further development, manufacturing and commercialisation of carboplatin to be used with SonoCloud system for the treatment of recurrent glioblastoma
Analysis
Accord Healthcare implements next generation of Ci-DMS
The project has already reaped many benefits including greater accuracy and efficiency when dispensing material weights
Media
Accord Healthcare opens new UK factory to increase EU presence
New site to be EMENA centre for excellence and create more than 500 jobs
Pharmaceutical
Intas first Indian company to launch biosimilar in EU, US and Japan
The company has launched its first biosimilar, filgrastim, in Europe, through its wholly owned subsidiary Accord Healthcare
Subscribe now